More Canadians have access to Humira (adalimumab) for the treatment of ulcerative colitis

29 August 2017 - Humira (adalimumab) now reimbursed in British Columbia, Ontario, New Brunswick, Newfoundland and Labrador, Saskatchewan and Yukon. ...

Read more →

Posting of key milestones for CDR projects

14 August 2017 - Key milestones for CDR submissions, resubmissions, and requests for advice will now be posted within the ...

Read more →

Sask. woman calls on government to cover cystic fibrosis drug

4 August 2017 - A Beauval, Sask. woman wants the Canadian government to cover an expensive drug for her cystic ...

Read more →

Proposed revisions to CADTH’s biosimilar review process

1 August 2017 - Given the type of data required to support biosimilar authorization differs from that required for a biologic ...

Read more →

Quebec expects $1.2 billion in savings with new drug price deal

17 July 2017 - Government and generic-drug makers cap weeks of tense talks. ...

Read more →

Proposed revision to the procedure for the CADTH Common Drug Review and the CADTH Therapeutic Review Framework

13 July 2017 - CADTH is inviting stakeholder comments and feedback on proposed revisions to the Procedure for the CADTH Common ...

Read more →

Changes could reduce access to medications

6 July 2017 - In a speech in May, federal Health Minister Jane Philpott talked about rising prescription drug prices ...

Read more →

Supreme Court hands patent win to pharmaceutical companies

30 June 2017 - Canada’s Supreme Court on Friday struck down rules making it easy for generic drug firms to ...

Read more →

Quebec expects to save millions with overhaul of generic-drug purchasing process

28 June 2017 - Quebec is launching an attempt to save millions in drug costs through an overhaul of the ...

Read more →

Provinces lead the way towards pharmacare in Canada

24 June 2017 - Canada is the only country in the world that has a universal health care system that does ...

Read more →

Canada pays more for prescription drugs for common conditions than other wealthy countries: CMAJ study

12 June 2017 - Canada had second highest costs when compared to nine other affluent countries with universal health care. ...

Read more →

Subsequent entry products for non-biological complex drugs

9 June 2017 - In order to reflect the current environment for subsequent entry non-biological complex drugs, CADTH, in consultation ...

Read more →

CADTH publishes final recommendations for two Servier medicines

25 May 2017 - CADTH has published outcomes for edoxaban tosylate (Lixiana) and ivabradine hydrochloride (Lancora). ...

Read more →

US drug prices are so high that Canada wants other countries as reference points

22 May 2017 - How high are drug prices in the US? So high that the Canadian government may remove ...

Read more →

Earlier access to new drugs could solve Canada's affordability crisis

23 May 2017 - Policymakers are fiercely debating how to tackle the soaring costs of prescription drugs in Canada.  ...

Read more →